3 Mid-Cap Stocks to Avoid: Toll Brothers, Zimmer Biomet, CNA Financial

Mid-cap stocks can offer solid growth without the mega-cap risks, but some just dont cut it against bigger players or fresh disruptors. Today, were flagging three to skip: Toll Brothers, Zimmer Biomet, and CNA Financial. These luxury homebuilders, orthopedic giants, and insurance pros are showing weak spots in sales pipelines, growth rates, and returns that lag their peers. Toll Brothers sales backlog has dropped nine point four percent yearly for two years straight, with projections tanking six point seven percent over the next twelve months. Zimmer Biomet grew revenue four point five percent yearly over five years, slower than healthcare rivals. CNA Financials net premiums grew just seven point two percent lately, earnings per share two point two percent, and book value per share fell one point seven percent over five years. Steer clear of these for now, and check out stronger picks with better pipelines and profits to keep your portfolio popping without the drama. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/901c1914c684a1dc